Author:
Liu Dai-Huo,Zhao Wei-Wei,Li Zong-Xiao
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Fumihiro T, Tetsuro M, Tomohiro T, Lchiro A. A case of advanced pancreatic cancer treated with gemcitabine hydrochloride. Jpn J Cancer Chemother. 2003;30:1147–9.
2. Lee JL, Kim SC, Kim JH, Lee SS, Kim TW, Park DH, Seo DW, Lee SK, Kim MH, Kim JH, Park JH, Shin SH, Han DJ. Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma. Surgery. 2012;152:851–62.
3. William P, Peng H, Varsha G. Preclinical characteristics of gemcitabine. Anticancer Drug. 1995;6:7–13.
4. Hertel LW, Kroin JS. Synthesis of 2-deoxy-2,2-difluoro-d-ribose and 2-deoxy-2,2-difluoro-d-ribofuranosyl nucleosides. J Org Chem. 1988;53:2406–9.
5. Wang YH, Wang XH, Qiu ZB. Synthesis of gemcitabine hydrochloride. Chin J Pharm. 2007;38:249–51 (in chinese).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献